Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion - PubMed (original) (raw)
Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion
Hsiao D Lieu et al. Circulation. 2003.
Abstract
Background: LDL receptor-deficient "apolipoprotein (apo)-B100-only" mice (Ldlr-/-Apob100/100 have elevated LDL cholesterol levels on a chow diet and develop severe aortic atherosclerosis. We hypothesized that both the hypercholesterolemia and the susceptibility to atherosclerosis could be eliminated by switching off hepatic lipoprotein production.
Methods and results: We bred Ldlr-/-Apob100/100 mice that were homozygous for a conditional allele for Mttp (the gene for microsomal triglyceride transfer protein) and the inducible Mx1-Cre transgene. In these animals, which we called "Reversa mice," the hypercholesterolemia could be reversed, without modifying the diet or initiating a hypolipidemic drug, by the transient induction of Cre expression in the liver. After Cre induction, hepatic Mttp expression was virtually eliminated (as judged by quantitative real-time PCR), hepatic lipoprotein secretion was abolished (as judged by electron microscopy), and LDLs were virtually eliminated from the plasma. Intestinal lipoprotein production was unaffected. In mice fed a chow diet, Cre induction reduced plasma cholesterol levels from 233.9+/-46.0 to 37.2+/-6.5 mg/dL. In mice fed a high-fat diet, cholesterol levels fell from 525.7+/-32.2 to 100.6+/-14.3 mg/dL. The elimination of hepatic lipoprotein production completely prevented both the development of atherosclerosis and the changes in gene expression that accompany atherogenesis.
Conclusions: We developed mice in which hypercholesterolemia can be reversed with a genetic switch. These mice will be useful for understanding gene-expression changes that accompany the reversal of hypercholesterolemia and atherosclerosis.
Similar articles
- Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
Véniant MM, Zlot CH, Walzem RL, Pierotti V, Driscoll R, Dichek D, Herz J, Young SG. Véniant MM, et al. J Clin Invest. 1998 Oct 15;102(8):1559-68. doi: 10.1172/JCI4164. J Clin Invest. 1998. PMID: 9788969 Free PMC article. - Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM, Sullivan MA, Kim SK, Ambroziak P, Chu A, Wilson MD, Hellerstein MK, Rudel LL, Walzem RL, Young SG. Véniant MM, et al. J Clin Invest. 2000 Dec;106(12):1501-10. doi: 10.1172/JCI10695. J Clin Invest. 2000. PMID: 11120757 Free PMC article. - Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM, Withycombe S, Young SG. Véniant MM, et al. Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1567-70. doi: 10.1161/hq1001.097780. Arterioscler Thromb Vasc Biol. 2001. PMID: 11597927 Review. - The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.
Larsson SL, Skogsberg J, Björkegren J. Larsson SL, et al. J Biol Chem. 2004 Jan 9;279(2):831-6. doi: 10.1074/jbc.M303057200. Epub 2003 Oct 28. J Biol Chem. 2004. PMID: 14583618 - Diet, plasma lipoproteins and experimental atherosclerosis in baboons (Papio sp.).
Kushwaha RS, McGill HC Jr. Kushwaha RS, et al. Hum Reprod Update. 1998 Jul-Aug;4(4):420-9. doi: 10.1093/humupd/4.4.420. Hum Reprod Update. 1998. PMID: 9825856 Review.
Cited by
- A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake.
Martini T, Gobet C, Salati A, Blanc J, Mookhoek A, Reinehr M, Knott G, Sordet-Dessimoz J, Naef F. Martini T, et al. Nat Commun. 2024 Sep 28;15(1):8422. doi: 10.1038/s41467-024-52751-2. Nat Commun. 2024. PMID: 39341814 Free PMC article. - Mutagenesis on a complex mouse genetic background by site-specific nucleases.
Davies B, Trelfa L, Rashbrook VS, Drydale E, Martin R, Bai B, Golebka J, Biggs DS, Channon KM, Bhattacharya S, Douglas G. Davies B, et al. Transgenic Res. 2024 Aug 1. doi: 10.1007/s11248-024-00399-5. Online ahead of print. Transgenic Res. 2024. PMID: 39088185 - A suite of genome-engineered hepatic cells provides novel insights into the spatiotemporal metabolism of apolipoprotein B and apolipoprotein B-containing lipoprotein secretion.
Meurs A, Ndoj K, van den Berg M, Marinković G, Tantucci M, Veenendaal T, Kuivenhoven JA, Klumperman J, Zelcer N. Meurs A, et al. Cardiovasc Res. 2024 Sep 21;120(11):1253-1264. doi: 10.1093/cvr/cvae121. Cardiovasc Res. 2024. PMID: 38833612 Free PMC article. - Pig and Mouse Models of Hyperlipidemia and Atherosclerosis.
Getz GS, Reardon CA. Getz GS, et al. Methods Mol Biol. 2022;2419:379-411. doi: 10.1007/978-1-0716-1924-7_24. Methods Mol Biol. 2022. PMID: 35237978 - Trafficking of Mononuclear Phagocytes in Healthy Arteries and Atherosclerosis.
Tomas L, Prica F, Schulz C. Tomas L, et al. Front Immunol. 2021 Oct 25;12:718432. doi: 10.3389/fimmu.2021.718432. eCollection 2021. Front Immunol. 2021. PMID: 34759917 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases